Revenue Merck KGaA on all time high (consensus analysts)

Tomorrow the German Merck KGaA KGaA will publish her past quarter's results. Based on the analyst's estimates both the revenue and the net profit would be on the highest levels in years. For this year most of the analyst expect a total sales of 15,07 billion euros. The expectations of the revenue would mean a record revenue for the company. This is rather significant more than the 2015's revenue of 12,84 billion euros.

Historical revenues and results Merck KGaA KGaA plus taxations 2016

For 2016 the analysts estimate a record net profit of 2,49 billion euros. For the current year the consensus of the result per share is a profit of 6,01 euros. With these estimates the PE-ratio equals 15,79.

The average of the dividends estimates is at 1,23 euros. Merck KGaA KGaA's dividend return consequently equals 1,3 percent. The average dividend yield of the pharmaceutical company equals 0,43 percent.

Most recent target prices around 103 euros

Merck KGaA KGaA is being covered by 20 analysts (only based on fundamental analysis). The average target price for the stock is at 101,11 euros. This is around 6 percent more than the current stock price of 94,87 euros. Goldman Sachs , Societe Generale and Exane BNP Paribas recently provided recommendations for the company.

Based on the number of outstanding shares Merck KGaA KGaA's market capitalization equals 12,26 billion euros.

At 11.28 the stock traded at 1,38 percent higher at 94,87 euros.

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.